Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus and NB-UVB for Vitiligo
NCT00807690Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Nov 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of Tacrolimus Ointment 0.1% Iwaki in Vitiligo (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Morphometric registration of symmetric target lesions at 24 weeks. Started Nov 2005; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT00807690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807690.